Peptides derived from the env gene of the feline immunodeficiency virus and their applications
CA 2306441 C · Owner: Richardson, Jennifer · Inventors: Moraillon, Anne; Sonigo, Pierre; Richardson, Jennifer
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns peptides derived from the FIV (feline immunodeficiency virus) env gene and their immunoprophylactic applications (prevention and treatment of feline immunodeficiency). Said peptides capable of inducing a certain degree of protection against FIV infection are selected from the group consisting of: peptides containing 12 to 19 amino acids and whose sequence corresponds to SEQ ID NO:1 below: Lys-Lys-Gly-Leu-Gln-Gln-Leu-Gln-Glu-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-Gly-Asn. (SEQ ID NO:1); and peptides of not more than 50 aminoacids comprising said sequence SEQ ID NO:1.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 15, 1998 and granted May 10, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 15, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 15, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.